ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

Nearly 30% of pancreatic ductal adenocarcinomas (PDACs) exhibit a marked overexpression of monocarboxylate transporter 1 (MCT1) offering a unique opportunity for therapy. However, biochemical inhibitors of MCT1 have proven unsuccessful in clinical trials. In this study, we present an alternative app...

Cijeli opis

Bibliografski detalji

Glavni autori:	Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs, Shun Ishiyama, Taha Ahmedna, Il Minn, Nilofer Azad, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Shibin Zhou, Bert Vogelstein, Kathleen Gabrielson, Surojit Sur
Format:	Artigo
Jezik:	Inglês
Izdano:	eLife Sciences Publications Ltd 2025-05-01
Serija:	eLife
Teme:	cancer biology pancreatic cancer targeted therapy MCT1 solute channel
Online pristup:	https://elifesciences.org/articles/94488
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!